We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New Robotic Platform Performs World’s First Magnetic Robotic-Assisted Surgeries

By HospiMedica International staff writers
Posted on 07 Jul 2021
The first ever magnetic robotic-assisted surgical procedures have been performed using a new robotic platform in development that is designed to deliver clinical benefit to patients, better visualization and control to surgeons, and higher efficiency to hospitals.

The Levita Robotic Platform from Levita Magnetics (Menlo Park, CA, USA) was used to complete a reduced-incision laparoscopic cholecystectomy (gallbladder removal), as part of a current clinical study of the system. The new robotic platform is intended to deliver the clinical benefits of the company’s first commercial product, the Levita Magnetic Surgical System, including less pain, faster recovery and fewer scars for patients. The platform is intended to improve visualization, maintain surgeon control of instruments, and increase hospital efficiency with fewer assistive personnel required to conduct the procedures. With its compact footprint, the robotic platform is specially designed for high volume ambulatory or same-day discharge abdominal surgeries. The aim of these combined benefits is to increase the volume of high-quality, efficiently performed procedures while improving surgical access to patients.

Image: The Levita Robotic Platform (Photo courtesy of Levita Magnetics)
Image: The Levita Robotic Platform (Photo courtesy of Levita Magnetics)

The Levita Magnetic Surgical System enables reduced-port laparoscopic surgical procedures designed to minimize the footprint of surgery. The system, which consists of an external magnet placed on the skin that controls a shaftless detachable grasper, enables instruments to move without the constraints of a fixed-position pivot point. The Levita Magnetic Surgical System is indicated in the US to grasp and retract the body and the fundus of the gallbladder in laparoscopic cholecystectomy procedures; the liver in bariatric procedures; the prostate and periprostatic tissue in prostatectomy procedures; and the colon, rectum, and peri-colorectal tissue in colorectal procedures to facilitate access and visualization of the surgical site. The device is indicated for use in patients with a body mass index (BMI) range of 20 to 60 kg/m2.

“I am pleased to have the opportunity to perform the world’s first procedures using this innovative robotic platform. The first surgery was a challenging acute cholecystitis, nevertheless, the procedure went very smoothly and the patient had an outstanding recovery with no complications reported at 30 days post-procedure. Since then, we have performed two additional acute cholecystectomies using the robotic platform, with both patients enrolled and treated on the same day,” said Dr. Ignacio Robles, a minimally invasive surgeon who used the new robotic platform to complete the reduced-incision laparoscopic cholecystectomy. “The combination of Levita’s magnetic technology within a robotic platform shows great promise to improve surgeon control and efficiency during surgical procedures. I’m excited to continue participating in this clinical study to further support the development of this platform.”

“We are taking Magnetic Surgery to the next level with this disruptive approach. Our robotic platform is designed to be the first to enable the clinical benefits of a less invasive procedure with fewer incisions, while allowing the surgeon full control of the platform and surgical instruments directly beside the patient,” said Dr. Alberto Rodriguez-Navarro, minimally invasive surgeon, founder and CEO of Levita Magnetics. “We believe enabling timely access to needed surgery has a direct impact on the quality of life for patients and may reduce the risk of complications or death due to the underlying disease. Our ultimate goal is to globally increase the ability of surgeons and hospitals to provide more patients access to better surgical procedures within their communities. We are advancing our clinical study and plan to submit the Levita Robotic Platform to the U.S. FDA for clearance in late 2021. We aim to deliver what society is expecting from surgical robotics.”

Related Links:
Levita Magnetics


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Surgial Headlight
MedLED Chrome

Latest Surgical Techniques News

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Living Knee Replacement to Revolutionize Osteoarthritis Treatment

Soft, Flexible, Battery-Free Implant Continuously Monitors Bladder Function